HC Wainwright & Co. Reiterates Buy on ChromaDex, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on ChromaDex (NASDAQ:CDXC) and maintained a $6 price target, as stated by analyst Raghuram Selvaraju.
August 09, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on ChromaDex and maintained a $6 price target, indicating continued confidence in the company's prospects.
The reiteration of a Buy rating and maintenance of a $6 price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and potentially drive short-term price appreciation for ChromaDex.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100